Abstract:Introduction Hereditary spherocytosis (HS) is a congenital haemolytic disorder, resulting from plasma membrane protein deficiency of red blood cells (RBCs). Typical pathological signs are anemia, jaundice, and splenomegaly; in newborns, jaundice is the main symptom. Material and Methods This study focused on the state of art about the HS diagnosis, from traditional to innovative methods, including diagnostic algorithms that can be applied for pediatric and adult patients, for different laboratory diagnostic levels. Results The first erythrocyte parameters used for HS diagnosis were the mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), and red blood cell distribution width (RDW); nowadays new parameters are used in blood cell counter. Advia analyzers (Siemens Medical Solutions) supply the hyper‐dense cell percentage (% Hyper), which reflects the red blood cells hyperchromia. Sysmex instruments (i.e. XT‐4000i, XE‐5000, XN‐Series) provide the MicroR, that is the percentage of erythrocytes smaller than 60 fL, Hypo‐He, which is the percentage of erythrocytes with a content of hemoglobin less than 17 pg and % Hyper‐He, which represents the percentage of RBC with cellular hemoglobin content higher than 49 pg. CELL‐DYN Sapphire (Abbott Diagnostics) introduced the HPR parameter (% HPR), which represents the erythrocytes with hemoglobin > 410 g/L. Beckman Coulter instruments supply the mean sphered corpuscular volume (MSCV), which is the average volume of all erythrocytes, including mature erythrocytes and reticulocytes. Other reference tests for screening and diagnosis of HS are the acidified glycerol lysis test (AGLT), the eosin‐5‐maleimide (EMA) binding test and genetic testing by next‐generation sequencing. Conclusions The diagnostic workup of hereditary spherocytosis could be improved thanks to all the available tests, including new molecular tools. However, it requires synergy between clinicians and laboratory staff, evaluating clinical manifestations, all available data related to the disease and the prognosis to fill the diagnostic gaps in the near future.

A Rare Case of Iron Overload in Hereditary Spherocytosis: A Case Report

Iron Chelators Reverse Organ Damage in Type 4B Hereditary Hemochromatosis Case Reports

Iron overload in hereditary spherocytosis: Are genetic factors the cause?

Naturopathic Management of Hereditary Spherocytosis: A Case Report

A large family of hereditary spherocytosis and a rare case of hereditary elliptocytosis with a novel SPTA1 mutation underdiagnosed in Taiwan: A case report and literature review

Clinical manifestations of adult hereditary spherocytosis with novel SPTB gene mutations and hyperjaundice: A case report

A Case of Adult Hereditary Spherocytosis Concomitant with Gilbert Syndrome Caused by Mutations in SPTB and UGT1A1

S4408 Iron Overload: A Case of Hidden Hemochromatosis

Precise diagnosis of a hereditary spherocytosis patient with complicated hematological phenotype

Overview on Hereditary Spherocytosis Diagnosis

Detecting total toxicity in water using a mediated biosensor system with flow injection.

A novel SPTB gene mutation in neonatal hereditary spherocytosis: a case report and literature review

Identification of novel mutations in hereditary spherocytosis patients by whole-exome sequencing

S4316 Possible Case Of Hereditary Hemochromatosis Overshadowed By Hepatic Sarcoidosis

The case of Claire Conroy: will administrative review safeguard incompetent patients?

The Correlation Between Clinical Phenotype and Genotype of Hereditary Spherocytosis

Physiologically important secondary modifications of red cell membrane in hereditary spherocytosis-evidence for in vivo oxidation and lipid rafts protein variations

S4234 Iron Sights: A Confused Presentation of Hemochromatosis

Diagnosis and Management of Genetic Iron Overload Disorders

A Case Report of Hemolytic Hyponatremia

Neonatal hereditary spherocytosis caused by a de novo frameshift mutation of the <i>SPTB</i> gene characterized by hydrops fetalis A case report